Monday, Aug. 24, 2009 | 3:46 p.m.
Danny Gans’ friends and family maintained that the late entertainer had little use personally for prescription drugs, though his death in May was from an overdose of Dilaudid, (the generic is Hydromorphone) a painkiller. The source of the drug that killed Gans has not been identified.
Now the Board of Pharmacy is investigating Gans’ ownership interest in Green Valley Med, a distributor of pharmaceuticals and medical supplies to doctors.
Documents we obtained from the state reveal Gans had held a stake in the local pharmacy since 2003. The pharmacy board took Gans’ records from Green Valley Med in June, but will not reveal the nature of the documents seized.
Green Valley Med bills itself on its website as the “largest medical supplier in Southern Nevada.” We wanted to know if it carries Dilaudid. Owner Scot Silber seemed stunned last Monday when I asked about his business relationship with Gans. Silber confirmed the two were partners but wouldn’t say whether Green Valley Med carries Dilaudid. Coincidentally, the very next day Gans’ self-described friend, Channel 3 entertainment reporter Alicia Jacobs, detailed Gans’ ownership interest and reluctantly delved into the possibility that Gans obtained the lethal drug through that association.
Attorney Bob Massi, who represents Green Valley Med and doubles as its marketing director, declined to be interviewed but in an e-mail said, “The perception that is being portrayed of Danny Gans is disgusting. He was a great man, an ambassador to Las Vegas, and he is being smeared by an affiliation which was and has been a matter of public record.” Gans’ application for a stake in the pharmacy is posted to the right.
Business Interests
Friends and family of late entertainer Danny Gans say he had little use for prescription drugs, but Gans owned a significant part of a local pharmacy. State officials are investigating. Plus, authorities raid a local medical spa.
You can see the story tonight on In Business Las Vegas, Las Vegas ONE, Cox Cable Channel 19.
Join the Discussion:
Check this out for a full explanation of our conversion to the LiveFyre commenting system and instructions on how to sign up for an account.
Full comments policy